Fostemsavir Active in Multidrug-Resistant HIV-1 Infection
Reduction in HIV-1 RNA level significantly greater for fostemsavir versus placebo in randomized cohort
Workers at Risk for COVID-19 Exposure Can Access Online Training
The National Institute of Environmental Health Sciences launched virtual training website to protect workers
National Health Spending Expected to Increase Through 2028
National health expenditures expected to represent 19.7 percent of gross domestic product by 2028
Hep C Testing, Treatment Rates Low at Federally Qualified Health Centers
Only 15 percent of individuals with identified opioid use disorder were tested for hepatitis C virus
Second Case of HIV-1 Cure After Stem Cell Transplant Reported
HIV-1 viral load remained undetectable in plasma in patient up to 30 months after transplant
New HIV PrEP Drug Not Cost-Effective Compared With Generic
F/TAF would avert 2,101 fractures, 25 cases of end-stage renal disease, but not deemed cost-effective
2018 Health Care Spending Up Due to Higher Prices
2018 uptick in utilization first seen in years, but impact dwarfed by price increases
Female Clinical Chairs Paid Significantly Less Than Men
Findings based on study of 550 clinical department chairs at 29 public U.S. medical schools
Long-Acting Cabotegravir, Rilpivirine Noninferior in HIV-1
Studies demonstrate noninferiority to standard oral therapy, dolutegravir-abacavir-lamivudine
Considerable Increase Seen in List, Net Prices of Branded Drugs
From 2007 to 2018, list prices increased 159 percent, while net prices increased by 60 percent
